These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20202231)
41. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171 [TBL] [Abstract][Full Text] [Related]
42. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427 [TBL] [Abstract][Full Text] [Related]
43. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma. Ren J; Huan Y; Li F; Wang H; Ge Y; Chang Y; Yin H; Sun L J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203 [TBL] [Abstract][Full Text] [Related]
44. Inter-observer variation and diagnostic efficacy of apparent diffusion coefficient (ADC) measurements obtained by diffusion-weighted imaging (DWI) in small renal masses. Ponhold L; Javor D; Heinz-Peer G; Sevcenco S; Hofstetter M; Baltzer PA Acta Radiol; 2016 Aug; 57(8):1014-20. PubMed ID: 26486599 [TBL] [Abstract][Full Text] [Related]
45. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Jin G; An N; Jacobs MA; Li K Acad Radiol; 2010 Apr; 17(4):456-63. PubMed ID: 20207316 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Heusner TA; Kuemmel S; Koeninger A; Hamami ME; Hahn S; Quinsten A; Bockisch A; Forsting M; Lauenstein T; Antoch G; Stahl A Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1077-86. PubMed ID: 20204355 [TBL] [Abstract][Full Text] [Related]
47. Feasibility study of reduced field of view diffusion-weighted magnetic resonance imaging in head and neck tumors. Vidiri A; Minosse S; Piludu F; Curione D; Pichi B; Spriano G; Marzi S Acta Radiol; 2017 Mar; 58(3):292-300. PubMed ID: 27287402 [TBL] [Abstract][Full Text] [Related]
48. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. Rosenkrantz AB; Mussi TC; Spieler B; Melamed J; Taneja SS; Huang WC J Magn Reson Imaging; 2012 Jun; 35(6):1478-83. PubMed ID: 22282396 [TBL] [Abstract][Full Text] [Related]
49. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma. Park JJ; Kim CK AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487 [TBL] [Abstract][Full Text] [Related]
50. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Zhou G; Chen X; Zhang J; Zhu J; Zong G; Wang Z Eur J Radiol; 2014 Nov; 83(11):2013-8. PubMed ID: 25213829 [TBL] [Abstract][Full Text] [Related]
51. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI. Choi YA; Kim CK; Park SY; Cho SW; Park BK AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231 [TBL] [Abstract][Full Text] [Related]
52. [Clinical analysis of 123 cases of transitional cell carcinoma (TCC) of upper urinary tract]. Liang YY; Dai YP; Huang ZY; Zheng KL; Mei H Ai Zheng; 2005 Jan; 24(1):91-4. PubMed ID: 15642209 [TBL] [Abstract][Full Text] [Related]
53. Optimal b value in diffusion-weighted imaging for differentiation of abdominal lesions. Koc Z; Erbay G J Magn Reson Imaging; 2014 Sep; 40(3):559-66. PubMed ID: 24115207 [TBL] [Abstract][Full Text] [Related]
54. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Bozkurt M; Doganay S; Kantarci M; Yalcin A; Eren S; Atamanalp SS; Yuce I; Yildirgan MI Eur J Radiol; 2011 Nov; 80(2):224-8. PubMed ID: 20598823 [TBL] [Abstract][Full Text] [Related]
55. The influence of diffusion gradient direction on diffusion-weighted imaging of breast mass-like lesions at 3.0T. Yao F; Li Y; Xiao Y; Zheng D; Zhang Y; Cheng J Acta Radiol; 2017 Oct; 58(10):1182-1188. PubMed ID: 28273744 [TBL] [Abstract][Full Text] [Related]
56. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors. Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332 [TBL] [Abstract][Full Text] [Related]
58. Performance of diffusion-weighted MRI post-CT urography for the diagnosis of upper tract urothelial carcinoma: Comparison with selective urine cytology sampling. Akita H; Kikuchi E; Hayakawa N; Mikami S; Sugiura H; Oya M; Jinzaki M Clin Imaging; 2018; 52():208-215. PubMed ID: 30125847 [TBL] [Abstract][Full Text] [Related]
59. Comparison of ADC values in different malignancies of the skeletal musculature: a multicentric analysis. Surov A; Nagata S; Razek AA; Tirumani SH; Wienke A; Kahn T Skeletal Radiol; 2015 Jul; 44(7):995-1000. PubMed ID: 25916616 [TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. Takeuchi M; Suzuki T; Sasaki S; Ito M; Hamamoto S; Kawai N; Kohri K; Hara M; Shibamoto Y Acad Radiol; 2012 Jul; 19(7):827-33. PubMed ID: 22341371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]